OnKure Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2022 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
OnKure Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2022 to Q2 2025.
  • OnKure Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2025 was $581K, a 17.9% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2025 $581K +$88K +17.9% Jun 30, 2025 10-Q 2025-08-12
Q1 2025 $676K +$130K +23.8% Mar 31, 2025 10-Q 2025-05-06
Q4 2024 $770K +$292K +61.1% Dec 31, 2024 10-Q 2025-08-12
Q3 2024 $440K -$566K -56.3% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $493K -$593K -54.6% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $546K -$642K -54% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $478K -$814K -63% Dec 31, 2023 10-K 2025-03-10
Q3 2023 $1.01M -$180K -15.2% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $1.09M -$197K -15.4% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $1.19M -$194K -14% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $1.29M Dec 31, 2022 10-K 2024-03-28
Q3 2022 $1.19M Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $1.28M Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $1.38M Mar 31, 2022 10-Q 2022-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.